Why Simply Booking a Booth Is Not Enough for Korean Companies at CPHI Milan 2026

Why Simply Booking a Booth Is Not Enough for Korean Companies at CPHI Milan 2026

CPHI Milan 2026 will take place from October 6 to 8, 2026, at Fiera Milano in Italy.

CPHI is one of the pharmaceutical industry’s largest B2B events, bringing together companies from across the supply chain, including active pharmaceutical ingredients, contract development and manufacturing, finished dosage forms, pharmaceutical machinery, packaging, and logistics.

The 2025 edition in Frankfurt attracted approximately 60,000 attendees and more than 2,900 exhibiting companies, according to figures published by the organizer.

At that scale, it is easy to assume that simply exhibiting will create plenty of business opportunities.

In reality, the size of the event can also make it more difficult for an unprepared company to find the right partners. Thousands of companies and tens of thousands of visitors may be present, but many of them will have little relevance to a specific exhibitor’s products or commercial goals.

Securing a booth and displaying products does not automatically bring qualified buyers to the stand.

To generate meaningful results at CPHI, a company should be able to answer several questions before the event begins:

• Which companies and decision-makers should we meet?

• What does each potential partner need to verify about our business?

• What evidence and materials should we present during the meeting?

• What should happen after the first conversation?

• Which outcomes would make the exhibition a commercial success?

For Korean companies exhibiting in Europe, there is another challenge. They must prepare their buyer strategy while also managing booth booking, organizer communication, logistics, furniture orders, registration, travel, and on-site operations.

This article looks at how Korean API, CDMO, and finished dosage companies should prepare differently for CPHI—and how they can allocate limited internal resources between exhibition operations and commercial preparation.

CPHI May Look Like One Exhibition, but It Contains Several Different Markets

CPHI brings the pharmaceutical supply chain together under one roof, but the commercial purpose of each exhibitor and visitor can be very different.

The major exhibition zones at CPHI Milan 2026 include:

1. API

2. • Contract Manufacturing Services

3. • Finished Dosage Formulations

4. • Bio Production

5. CRO

6. • Excipients & Fine Chemicals

7. • Machinery & Equipment

8. • Packaging & Drug Delivery

1. • The 2026 event also introduces or highlights dedicated areas such as:

• AI & Tech

• • Contamination Control

• • Cold Chain & Logistics

• Labelling

These zones are not simply an organizational tool for the exhibition floor. They reflect the different purchasing needs, partnership models, and commercial questions found across the pharmaceutical supply chain.

Companies visiting the API zone may be evaluating ingredient quality, regulatory documentation, and supply reliability.

Visitors to the Contract Manufacturing area may be searching for a partner capable of development, technology transfer, scale-up, or commercial manufacturing.

Companies exploring Finished Dosage Formulations may be looking for products that can be registered, licensed, distributed, or commercialized in specific markets.

This means that it is rarely effective for every exhibitor to rely on the same corporate presentation and the same sales message.

Even the word “buyer” can refer to very different people at CPHI:

• • Procurement and sourcing managers

• • Quality and regulatory specialists

• • Technology transfer and manufacturing teams

• • Business development executives

• • Distributors

• • Licensing partners

• • Marketing authorization holders

• • Supply chain and purchasing professionals

The evidence they expect to see—and the next step they are prepared to take—will differ according to their role.

How Should API, CDMO, and Finished Dosage Companies Prepare Differently?

The main differences can be summarized as follows.

API Companies Need to Prove More Than the Size of Their Product Portfolio

An API company may be tempted to focus on how many ingredients it manufactures.

However, prospective customers are more interested in whether an ingredient can be evaluated, registered, incorporated into a product, and supplied consistently over time.

Depending on the product and target market, an API exhibitor may need to prepare information such as:

• • Key product specifications

• • CEP availability and current status

• • The scope of ASMF, DMF, or other regulatory documentation available

• • Certificates of analysis and impurity information

• • Nitrosamine and other quality-risk management information

• • Manufacturing facilities and annual capacity

• • Minimum order quantities and lead times

• • Change-control and supply continuity procedures

• • Previous registrations or export experience

For an API company, a high number of booth visitors is not necessarily the most useful measure of success.

More meaningful indicators include:

• • Requests for samples

• • Requests to review specifications

• • Follow-up meetings with quality teams

• • Registration project discussions

• • Supplier qualification or feasibility reviews

These actions suggest that the prospective customer is moving beyond general interest and beginning a real evaluation process.

CDMOs Need to Demonstrate How They Execute Projects

CDMO companies often emphasize facilities, equipment, and manufacturing scale.

Those factors matter, but customers usually want to understand something more fundamental:

Can this company take responsibility for our project and move it successfully through development, technology transfer, scale-up, and manufacturing?

A CDMO should be prepared to answer questions such as:

• • At which development stages can the company provide support?

• • How is technology transfer managed?

• • Can the company receive and validate a client’s process and analytical methods?

• • Is the required capacity available within the client’s timeline?

• • How are milestones, changes, and delays managed?

• • How are quality responsibilities and communication structured?

Rather than relying on a general statement such as “we can manufacture this product,” a CDMO should prepare:

• • Supported dosage forms and technology platforms

• • Scope of services from development through commercial manufacturing

• • Technology-transfer procedures

• • Expected timelines and project milestones

• • Available manufacturing capacity

• • Quality systems and allocation of responsibilities

• • Anonymized examples of relevant projects

• • The process followed after receiving an RFP

For a CDMO, meaningful exhibition outcomes may include:

• • NDA discussions

• • RFP requests

• • Confirmed technical meetings

• • Facility or quality-audit discussions

• • Preliminary project-fit assessments

The strongest CDMO message is usually not simply what the company can manufacture, but how it will manage the customer’s project.

Finished Dosage Companies Need to Show a Route to Market

Finished dosage companies often focus their presentations on ingredients, indications, or product benefits.

However, distributors and licensing partners also need to determine whether the product can actually be registered, supplied, and sold in their market.

The company may therefore need to prepare:

• • Product portfolio and indications

• • Current approval and registration status

• • Availability of CTD, quality, and manufacturing documentation

• • Stability data

• • Territory and licensing-rights status

• • Licensing or distribution terms

• • Pricing and minimum order quantities

• • Production and delivery conditions

• • Packaging and labelling capabilities

• • The responsibilities expected from a local registration or distribution partner

For a finished dosage company, stronger indicators of progress include:

• • Country-specific registration reviews

• • Territory-rights discussions

• • Requests for technical documentation

• • Price and MOQ negotiations

• • Distribution discussions

• • Confirmed follow-up meetings

In simple terms, API companies need to demonstrate quality and supply capability, CDMOs need to demonstrate project execution, and finished dosage companies need to demonstrate registration and commercialization potential.

CPHI Results Are Shaped Before the Exhibition Opens

At a major event, exhibitors may collect many business cards and contact details.

That does not mean that every contact represents a genuine commercial opportunity.

A more useful way to evaluate performance is to identify which meetings moved to a specific next stage, such as:

• • A sample or quality-document request

• • An NDA discussion

• • An RFP request

• • A follow-up meeting with technical or quality teams

• • A registration feasibility review

• • A territory-rights discussion

• • A distribution negotiation

• • A confirmed date for the next meeting

These outcomes usually require preparation before the event.

1. Define the Target More Precisely

“European buyers” is too broad to be a useful target.

An exhibitor should narrow the audience by:

• • Country

• • Company type

• • Product category

• • Commercial purpose

• • Decision-maker role

A German generic manufacturer evaluating a new API supplier is not looking for the same information as an Italian distributor reviewing finished products or a biotech company searching for a CDMO.

2. Request Meetings Before the Event

CPHI provides digital tools that allow participants to search companies and products, contact potential partners, and use networking areas or selected connection programs.

However, access to a platform does not automatically generate qualified meetings.

The exhibitor still needs to identify targets, write a relevant message, and confirm the schedule.

3. Adapt the Presentation to the Person in the Room

There is no need to present the same corporate deck in the same order to every visitor.

For example:

• • A quality specialist may need to see specifications and regulatory documentation first.

• • A business development executive may be more interested in commercial terms and market potential.

• • A technical specialist may want to understand platforms, process capability, and project experience.

The company may use the same core materials, but the order and emphasis should change according to the audience.

4. Prepare the Follow-Up Before the Meeting Happens

If the team starts searching for documents only after returning from the exhibition, the follow-up may already be too slow.

Before the event, the company should define:

• • Which materials will be sent after each type of meeting

• • Who is responsible for sending them

• • The deadline for the follow-up

• • How the next meeting will be proposed

• • How leads will be prioritized

Korean Exhibitors Must Manage Both Exhibition Operations and Commercial Preparation

There are two distinct categories of work involved in CPHI participation.

Both categories are essential.

In many companies, however, the same person is responsible for all of them.

For a Korean company participating in a European exhibition for the first time, the workload may also include:

• • Understanding unfamiliar organizer rules

• • Managing communication across languages and time zones

• • Finding and comparing local suppliers

• • Preparing international shipping and customs clearance

• • Tracking multiple application deadlines

• • Responding to last-minute changes

When time becomes limited, buyer lists, meeting materials, and sales preparation are often the first things to be delayed.

The purpose of reducing operational work is not simply to make the project more convenient.

The time saved needs to be actively reinvested in buyer research, meeting preparation, and follow-up.

What Support Options Are Available to Korean CPHI Exhibitors?

Korean companies do not necessarily need to manage the entire process internally.

In general, they can consider three types of support.

1. Korean Pavilions and Government-Supported Programs

A Korean pavilion can be useful for first-time exhibitors or companies looking to reduce participation costs.

Depending on the program, support may include:

• • Partial support for booth rental and construction

• • Shared pavilion operations

• • Administrative guidance

• • Marketing or consultation support

However, these programs usually involve an application and selection process. Exhibitors may also need to work within the location, design, branding, and operating rules of the pavilion.

This can be an efficient route for some companies, but it may be less suitable for a company that requires independent branding or greater control over its booth.

2. CPHI Organizer Tools and Programs

The organizer provides tools for company and product discovery, networking, and participant communication.

Companies with strong in-house English communication and business development capabilities can use these tools to identify and approach potential partners directly.

However, organizer tools do not create the company’s commercial materials or meeting strategy. The exhibitor still needs to prepare its value proposition, evidence, and follow-up process.

3. Private Exhibition Participation Services in Korea

Korea also has a growing number of services that support companies participating in overseas exhibitions.

Some providers offer broad, all-in-one assistance covering areas such as:

• • Booth booking

• • Booth construction

• • Logistics

• • Interpretation

• • Promotion

• • Buyer meeting support

Others focus on helping companies manage booth participation, organizer communication, administration, and preparation in a more structured way.

The important question is not simply which company is “the best.”

The service scope, operating method, and degree of internal control can vary considerably.

Why MyFair’s Participation Model Stood Out to Me

When researching overseas exhibitions, I often come across MyFair’s event introductions and practical participation guides.

The articles usually go beyond basic dates and venue information. They also explain booth booking procedures, organizer rules, and administrative tasks that exhibitors may easily overlook. I referred to several of these guides while researching CPHI as well.

That made me curious about how the company’s actual service works.

At first glance, MyFair appears similar to a traditional exhibition agency. It communicates with organizers, supports booth booking, and helps companies complete various participation tasks.

What felt different was the way the company appears to structure the working relationship.

Rather than asking the exhibitor to hand over every task and wait for the result, MyFair allows the company’s own staff to review and manage the preparation process through a dedicated workspace while receiving support from exhibition professionals.

In other words, the exhibitor appears to retain visibility and control over the project without having to process every operational task internally.

The service structure is also divided according to the level of support required, including:

• • Booth-booking-focused support

• • Participation preparation covering booth setup and administrative work

• • Expert support for major decisions and booth strategy

Among the participation models I reviewed, this combination of company-side management, a digital system, and expert support was particularly interesting.

It appears especially suitable for companies that:

• • Need an independently branded booth rather than a shared national pavilion

• • Want to exhibit individually but have limited international exhibition experience

• • Need internal visibility into tasks, schedules, and project history

• • Want the project to continue smoothly even if the internal person in charge changes

• • Need to focus internal resources on product materials and buyer meetings

• • Prefer to retain control over key decisions rather than outsource the entire process

On the other hand, a company that wants booth construction, logistics, interpretation, on-site support, and buyer meetings delivered in a single broad package may prefer an all-in-one provider such as Contenture or another full-service agency.

No single service is likely to be the best choice for every exhibitor.

The more important question is which responsibilities the company wants to retain internally and which ones should be supported externally.

Participation Services Should Be Evaluated by Resource Allocation, Not Only by Price

Managing the project directly may appear to be the cheapest option because there is no additional service fee.

However, the full investment should also include:

• • Internal staff time spent researching information and communicating with the organizer

• • Time spent managing multiple deadlines

• • The cost of finding and comparing local suppliers

• • Additional expenses caused by missed tasks or late changes

• • The opportunity cost of delaying buyer research and meeting preparation

• • The loss created by slow follow-up after the event

Using a professional service does not automatically improve exhibition results.

It becomes valuable only when the company uses the time saved for buyer development, meeting preparation, and post-event sales activity.

Before selecting a provider, exhibitors should ask:

• • How far does the service continue after booth booking?

• • Can the company’s staff directly review progress and schedules?

• • Who communicates with the organizer?

• • Are logistics, interpretation, and buyer matching provided directly or through partners?

• • Which costs are included, and which are additional?

• • Which tasks must still be handled internally?

• • How will the company use the time saved?

When external support reduces operational workload and the company deliberately reallocates that time to commercial preparation, the service may be more cost-effective from the perspective of the entire exhibition investment.

First-Time Exhibitors Can Combine Different Types of Support

A company does not need to rely on a single participation model.

Different types of support can be combined according to the company’s objectives and internal capabilities.

For example:

• • A government-supported program or Korean pavilion can help reduce participation costs.

• • CPHI’s digital platform can support company research and networking.

• • Independent participation can provide greater control over branding and booth location.

• • A professional participation service can reduce operational pressure when the internal team lacks experience.

• • An all-in-one provider may be appropriate when logistics, interpretation, and buyer support are major priorities.

• • A system-based participation service may suit a company that wants professional support while maintaining internal visibility and control.

The best option is not necessarily the one with the lowest service fee.

It is the one that fills the company’s capability gaps and allows the internal team to focus on the work closest to commercial results.

The Purpose of CPHI Is Not Simply to Operate a Booth

CPHI offers Korean pharmaceutical companies access to a large number of potential partners across the global supply chain.

But the scale of the event also means that an unprepared exhibitor may struggle to identify the right people and convert conversations into real business discussions.

API companies need to prepare evidence of quality and supply reliability.

CDMOs need to demonstrate their ability to execute projects.

Finished dosage companies need to show that their products can be registered and commercialized.

At the same time, every exhibitor must manage booth booking, organizer communication, logistics, and on-site operations.

Companies with sufficient internal experience and staff may choose to manage the process directly.

When operational work begins to interfere with buyer preparation, however, Korean pavilions, organizer tools, and private participation services can provide practical alternatives.

The purpose of external support is not simply to reduce the amount of work.

It is to help the company concentrate its limited time and expertise on product evidence, qualified buyers, meetings, and follow-up—the activities most closely connected to exhibition results.

For a company attending CPHI for the first time, it may be more realistic to define the areas where support is needed and compare several participation models rather than attempting to solve every task internally.